NEWARK, N.J.--(BUSINESS WIRE)--BioNeutral Group, Inc. (OTCBB:BONU), a specialty chemical technology-based life science company, reports that it has completed the required Independent Good Laboratory Practice (GLP) toxicity, chemistry and efficacy testing required for submission of its Ygiene™ Hospital Disinfectant to the U.S. Environmental Protection Agency (EPA). Based upon the completion of these required tests, the Company will be filing for EPA review of its Ygiene™ Hospital Disinfectant in the near future after consulting with its advisers.
